Pfizer's Vaccine, Biden's Task Force, and the Pandemic Response

P.M. Edition for Nov. 9. Drugmaker Pfizer announced that its Covid-19 vaccine, made in collaboration with German company BioNTech, has proven 90 percent effective in its latest trials. The hope that it could be federally approved by the end of the year sent U.S. stocks soaring. Wall Street Journal pharmaceutical reporter Jared Hopkins discusses the report, President-elect Joe Biden's new plan to combat the pandemic, and the hurdles that still need to be cleared to get a vaccine out to the public. Annmarie Fertoli hosts. Learn more about your ad choices. Visit megaphone.fm/adchoices